-
Living with MS
Explaining what MS is clearly and accurately
-
Services & Resources
Services and advice available to help you
-
Research
Interesting research and clinical abstracts
-
Support MSI
Lots of ways to get involved
-
About MS Ireland
More details about the work we do
Fingolimond
Oral MS therapy FTY720 (fingolimond) significantly reduces relapses and disability progression.
- Novartis International AG Press Release, 2009
- Download MS News Issue 86 two page news feature looks at a selection of the therapies being tested at present
As always, we recommend speaking to your neurologist about any changes to your treatment
Published by: MS Ireland/Novartis International AG on Tuesday October 20 2009
« Back to news index
Sign up to our eNews
Keep up to date with our eNews
Why support MS Ireland?
Find out why we could use your help.
© 2008-2011 MS Ireland
Web Development: Focus New Media
Web Development: Focus New Media